These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 30333834)

  • 1. Ligand Recognition Determines the Role of Inhibitory B Cell Co-receptors in the Regulation of B Cell Homeostasis and Autoimmunity.
    Tsubata T
    Front Immunol; 2018; 9():2276. PubMed ID: 30333834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD22 and Siglec-G: B-cell inhibitory receptors with distinct functions.
    Nitschke L
    Immunol Rev; 2009 Jul; 230(1):128-43. PubMed ID: 19594633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitory B cell co-receptors and autoimmune diseases.
    Tsubata T
    Immunol Med; 2019 Sep; 42(3):108-116. PubMed ID: 31532707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of inhibitory BCR co-receptors in immunity.
    Tsubata T
    Infect Disord Drug Targets; 2012 Jun; 12(3):181-90. PubMed ID: 22394175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sialic Acid Ligand Binding of CD22 and Siglec-G Determines Distinct B Cell Functions but Is Dispensable for B Cell Tolerance Induction.
    Özgör L; Meyer SJ; Korn M; Terörde K; Nitschke L
    J Immunol; 2018 Oct; 201(7):2107-2116. PubMed ID: 30143587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
    Meyer SJ; Linder AT; Brandl C; Nitschke L
    Front Immunol; 2018; 9():2820. PubMed ID: 30559744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Protein Tyrosine Phosphatase SHP-1 (PTPN6) but Not CD45 (PTPRC) Is Essential for the Ligand-Mediated Regulation of CD22 in BCR-Ligated B Cells.
    Alborzian Deh Sheikh A; Akatsu C; Abdu-Allah HHM; Suganuma Y; Imamura A; Ando H; Takematsu H; Ishida H; Tsubata T
    J Immunol; 2021 Jun; 206(11):2544-2551. PubMed ID: 33990399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD72 is an inhibitory pattern recognition receptor that recognizes ribosomes and suppresses production of anti-ribosome autoantibody.
    Akatsu C; Tsuneshige T; Numoto N; Long W; Uchiumi T; Kaneko Y; Asano M; Ito N; Tsubata T
    J Autoimmun; 2024 Jun; 146():103245. PubMed ID: 38754236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copresentation of antigen and ligands of Siglec-G induces B cell tolerance independent of CD22.
    Pfrengle F; Macauley MS; Kawasaki N; Paulson JC
    J Immunol; 2013 Aug; 191(4):1724-31. PubMed ID: 23836061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD72 negatively regulates signaling through the antigen receptor of B cells.
    Adachi T; Wakabayashi C; Nakayama T; Yakura H; Tsubata T
    J Immunol; 2000 Feb; 164(3):1223-9. PubMed ID: 10640734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for CD100-CD72 interactions in fine-tuning of B-cell antigen receptor signaling and homeostatic maintenance of the B-cell compartment.
    Kumanogoh A; Shikina T; Watanabe C; Takegahara N; Suzuki K; Yamamoto M; Takamatsu H; Prasad DV; Mizui M; Toyofuku T; Tamura M; Watanabe D; Parnes JR; Kikutani H
    Int Immunol; 2005 Oct; 17(10):1277-82. PubMed ID: 16113236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD72 negatively regulates B lymphocyte responses to the lupus-related endogenous toll-like receptor 7 ligand Sm/RNP.
    Akatsu C; Shinagawa K; Numoto N; Liu Z; Ucar AK; Aslam M; Phoon S; Adachi T; Furukawa K; Ito N; Tsubata T
    J Exp Med; 2016 Nov; 213(12):2691-2706. PubMed ID: 27810925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD22 and Siglec-G regulate inhibition of B-cell signaling by sialic acid ligand binding and control B-cell tolerance.
    Nitschke L
    Glycobiology; 2014 Sep; 24(9):807-17. PubMed ID: 25002414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD22-Binding Synthetic Sialosides Regulate B Lymphocyte Proliferation Through CD22 Ligand-Dependent and Independent Pathways, and Enhance Antibody Production in Mice.
    Matsubara N; Imamura A; Yonemizu T; Akatsu C; Yang H; Ueki A; Watanabe N; Abdu-Allah H; Numoto N; Takematsu H; Kitazume S; Tedder TF; Marth JD; Ito N; Ando H; Ishida H; Kiso M; Tsubata T
    Front Immunol; 2018; 9():820. PubMed ID: 29725338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Augmentation of signaling through BCR containing IgE but not that containing IgA due to lack of CD22-mediated signal regulation.
    Sato M; Adachi T; Tsubata T
    J Immunol; 2007 Mar; 178(5):2901-7. PubMed ID: 17312134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel binding site for Src homology 2-containing protein-tyrosine phosphatase-1 in CD22 activated by B lymphocyte stimulation with antigen.
    Zhu C; Sato M; Yanagisawa T; Fujimoto M; Adachi T; Tsubata T
    J Biol Chem; 2008 Jan; 283(3):1653-1659. PubMed ID: 18024433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [CD22 and CD72 are inhibitory receptors dominantly expressed in B lymphocytes and regulate systemic autoimmune diseases. German version].
    Tsubata T
    Z Rheumatol; 2016 Feb; 75(1):86-9. PubMed ID: 26830296
    [No Abstract]   [Full Text] [Related]  

  • 18. Lyn/CD22/SHP-1 and their importance in autoimmunity.
    Blasioli J; Goodnow CC
    Curr Dir Autoimmun; 2002; 5():151-60. PubMed ID: 11826756
    [No Abstract]   [Full Text] [Related]  

  • 19. The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound.
    Kelm S; Gerlach J; Brossmer R; Danzer CP; Nitschke L
    J Exp Med; 2002 May; 195(9):1207-13. PubMed ID: 11994426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD22 regulates B cell receptor-mediated signals via two domains that independently recruit Grb2 and SHP-1.
    Otipoby KL; Draves KE; Clark EA
    J Biol Chem; 2001 Nov; 276(47):44315-22. PubMed ID: 11551923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.